search
Back to results

Inhibitory rTMS in Dystonic Wilson Patients (WILSTIM)

Primary Purpose

Wilson Disease, Movement Disorders, Repetitive Transcranial Magnetic Stimulation

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Repetitive Transcranial Magnetic Stimulation (rTMS)
pre and post-rTMS electroencephalogram
WCRS
handwriting scale DPRE
visual analog scale of discomfort writing and parameters collected on touchpad
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Wilson Disease focused on measuring Wilson disease, Dystonia, Movement Disorders, Handwriting, Repetitive Transcranial Magnetic Stimulation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Wilson disease with focal right hand dystonia
  • No modification of medical treatment for 6 months
  • No botulinum toxin administration within the past four months
  • Right handed
  • Focal right hand dystonia
  • Cerebral Magnetic Resonance performed the last 6 months with no other lesion than met in Wilson disease
  • Over 18
  • Insurance policy holder
  • Informed consent

Exclusion Criteria:

  • Pregnant woman
  • Guardianship procedure
  • Seizure history
  • Other cerebral lesions on cerebral MRI than met in Wilson Disease
  • Unable to stay quiet for 30 minutes
  • Handwriting impossible
  • Contra-indications to repetitive Transcranial Magnetic Stimulation

Sites / Locations

  • Hospital Lariboisiere

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Active rTMS

Sham rTMS

Arm Description

Repetitive Transcranial Magnetic stimulation: 1 Hz rTMS, delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.

Placebo Transcranial Magnetic stimulation delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.

Outcomes

Primary Outcome Measures

immediate and significant improvement in writing
Improvement of handwriting performance immediately after one single 20 minutes session of inhibitory (1 Hz) repetitive transcranial magnetic stimulation over the left somatosensory cortex. quantitative test score of writing WCRS Active or sham stimulation will be randomly assigned to the patient and the other session will be performed 3 days later.

Secondary Outcome Measures

significant improvement in writing
improvement of other quantitative test scores of writing (VAS subjective discomfort writing, DPRE scales and parameters measured on touchpad) after a single session of 1 Hz rTMS inhibitory to the left CSS , compared to the scores achieved in the 24 hours before the session of rTMS. Active or sham stimulation will be randomly assigned to the patient and the other session will be performed 3 days later.
improvement of dystonia on the scale WDRS
Assessing the improvement of dystonia on the scale WDRS after a single session of 1 Hz rTMS inhibitory to the left CSS, compared to the scores achieved in the 24 hours before the session of rTMS. Active or sham stimulation will be randomly assigned to the patient and the other session will be performed 3 days later.
correlation between the scores and the other parameters of disease severity
Assess whether age, disease duration and the presence of cortical atrophy are inversely correlated with the evolution of scores.

Full Information

First Posted
October 24, 2013
Last Updated
June 14, 2021
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT01980433
Brief Title
Inhibitory rTMS in Dystonic Wilson Patients
Acronym
WILSTIM
Official Title
Study of Writing Improvement in Patients With Wilson Disease and Dystonia After One Session of Inhibitory Repetitive Transcranial Magnetic Stimulation
Study Type
Interventional

2. Study Status

Record Verification Date
June 2021
Overall Recruitment Status
Completed
Study Start Date
January 2014 (Actual)
Primary Completion Date
July 2015 (Actual)
Study Completion Date
July 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Wilson disease is a genetic disorder resulting in copper accumulation in liver, brain and eye. The neurologic complications include dystonic syndrome, which is a prolonged and excessive muscle activation responsible for abnormal postures. Hand dystonia prevents daily life activities such as writing, which is particularly disabling, since writing is the only mean of communication in these patients with significant slurred speech. Treatment is limited and only partially effective. Low frequency (<or=1Hz) repetitive transcranial magnetic stimulation (rTMS) has shown inhibiting properties when applied over the cortex. Since dystonia has been correlated to hyperactivation of the neurons of the somatosensory cortex (SSC), we hypothesize that one single 20-minute session of 1 Hz rTMS applied on left SSC will improve writing of the right dystonic hand, assessed immediately at the end of the session.
Detailed Description
This study investigates the handwriting performance of an homogeneous cohort of patients with Wilson disease and right handed dystonia, after one single inhibitory repetitive transcranial magnetic stimulation (rTMS). Fifteen patients with focal right hand dystonia will receive randomly either active or sham rTMS (1 Hz) to the left somatosensory cortex (SSC) in one single 20 minutes session. Handwriting performance will be measured immediately after this unique session (Visual analogic scale of subjective discomfort in writing, DPRE and WCRS scales, pen pressure and pen velocity measured on touchpad), compared to scores obtained 24 hours before the session. Three days later, the patient will receive the other session (sham rTMS or active rTMS) and the same parameters will be evaluated. This is a single-center, randomized, crossover, prospective, clinical and double-blind study (the rTMS session is performed by the neurophysiologist, but the patient and the neurologist who will perform the handwriting evaluation are blind to the session).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wilson Disease, Movement Disorders, Repetitive Transcranial Magnetic Stimulation
Keywords
Wilson disease, Dystonia, Movement Disorders, Handwriting, Repetitive Transcranial Magnetic Stimulation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
14 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Active rTMS
Arm Type
Experimental
Arm Description
Repetitive Transcranial Magnetic stimulation: 1 Hz rTMS, delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.
Arm Title
Sham rTMS
Arm Type
Sham Comparator
Arm Description
Placebo Transcranial Magnetic stimulation delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.
Intervention Type
Device
Intervention Name(s)
Repetitive Transcranial Magnetic Stimulation (rTMS)
Intervention Description
Inhibitory 1 Hz rTMS, delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.
Intervention Type
Other
Intervention Name(s)
pre and post-rTMS electroencephalogram
Intervention Description
to verify the absence of infraclinical seizures
Intervention Type
Other
Intervention Name(s)
WCRS
Intervention Description
Writer's cramp rating scale
Intervention Type
Other
Intervention Name(s)
handwriting scale DPRE
Intervention Description
handwriting in development and being evaluated by the NRC Wilson
Intervention Type
Other
Intervention Name(s)
visual analog scale of discomfort writing and parameters collected on touchpad
Primary Outcome Measure Information:
Title
immediate and significant improvement in writing
Description
Improvement of handwriting performance immediately after one single 20 minutes session of inhibitory (1 Hz) repetitive transcranial magnetic stimulation over the left somatosensory cortex. quantitative test score of writing WCRS Active or sham stimulation will be randomly assigned to the patient and the other session will be performed 3 days later.
Time Frame
up to 1 week
Secondary Outcome Measure Information:
Title
significant improvement in writing
Description
improvement of other quantitative test scores of writing (VAS subjective discomfort writing, DPRE scales and parameters measured on touchpad) after a single session of 1 Hz rTMS inhibitory to the left CSS , compared to the scores achieved in the 24 hours before the session of rTMS. Active or sham stimulation will be randomly assigned to the patient and the other session will be performed 3 days later.
Time Frame
up to 1 week
Title
improvement of dystonia on the scale WDRS
Description
Assessing the improvement of dystonia on the scale WDRS after a single session of 1 Hz rTMS inhibitory to the left CSS, compared to the scores achieved in the 24 hours before the session of rTMS. Active or sham stimulation will be randomly assigned to the patient and the other session will be performed 3 days later.
Time Frame
up to 1 week
Title
correlation between the scores and the other parameters of disease severity
Description
Assess whether age, disease duration and the presence of cortical atrophy are inversely correlated with the evolution of scores.
Time Frame
up to 1 week

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Wilson disease with focal right hand dystonia No modification of medical treatment for 6 months No botulinum toxin administration within the past four months Right handed Focal right hand dystonia Cerebral Magnetic Resonance performed the last 6 months with no other lesion than met in Wilson disease Over 18 Insurance policy holder Informed consent Exclusion Criteria: Pregnant woman Guardianship procedure Seizure history Other cerebral lesions on cerebral MRI than met in Wilson Disease Unable to stay quiet for 30 minutes Handwriting impossible Contra-indications to repetitive Transcranial Magnetic Stimulation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nathalie KUBIS, MD, PhD
Organizational Affiliation
Physiology Department, Lariboisière Hospital
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Jean-Marc TROCELLO, MD
Organizational Affiliation
Neurology, Lariboisière Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Lariboisiere
City
Paris
State/Province
Ile De France
ZIP/Postal Code
75010
Country
France

12. IPD Sharing Statement

Learn more about this trial

Inhibitory rTMS in Dystonic Wilson Patients

We'll reach out to this number within 24 hrs